loading

Finanzdaten der Promis Neurosciences Inc-Aktie (PMN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
24.28%
7.4601
6.0024 4.4347 2.7137 3.6767
Operating Income/Loss
24.28%
-7.4601
-6.0024 -4.4347 -2.7137 -3.6767
Nonoperating Income/Loss
98.05%
0.1122
5.7642 13.71 0.09 0.0416
Income/Loss From Continuing Operations Before Tax
2,985%
-7.3479
-0.2382 9.2758 -2.6237 -3.6351
Income/Loss From Continuing Operations After Tax
2,985%
-7.3479
-0.2382 9.2758 -2.6237 -3.6351
Net Income/Loss
2,985%
-7.3479
-0.2382 9.2758 -2.6237 -3.6351
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,075%
34.85
2.9662 30.02 19.77 19.53
Diluted Average Shares
1,151%
34.85
2.7856 30.07 19.77 19.53
Basic Earnings Per Share
950.00%
-0.21
-0.02 0.31 -0.13 -0.19
Diluted Earnings Per Share
950.00%
-0.21
-0.02 0.31 -0.13 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):